Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000274771 | SCV000344664 | uncertain significance | not provided | 2016-08-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001082959 | SCV000560873 | likely benign | Duchenne muscular dystrophy | 2024-12-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000274771 | SCV001938945 | benign | not provided | 2021-04-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002356394 | SCV002653960 | likely benign | Cardiovascular phenotype | 2019-12-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001835768 | SCV002093441 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2019-08-02 | no assertion criteria provided | clinical testing |